| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biology Department, Brookhaven National Laboratory, Upton, New York 11973
Azauracil was found to be the only one of several analogs of nucleic acid precursors tested in these studies which is capable of inducing tumors at a very early stage during seedling development in the genetically tumor-conditioned hybrid Nicotiana glauca x N. langsdorffii. Tumor induction by 6-azauracil was shown to be reversed by simultaneous treatments with uracil and actinomycin D as well as by posttreatments. Pre-treatments with the same substances proved to be ineffective.
The possible implications of the findings in view of the possible involvement of an abnormal species of RNA in the process of tumor induction by 6-azauracil are discussed.
1 Research performed at Brookhaven National Laboratory under the auspices of the U. S. Atomic Energy Commission.
2 Present address: Instituto di Genetica dell'Universita, Pisa, Italy.
Received 4/ 6/67. Accepted 9/29/67.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |